Long-term survival in adults with congenital heart disease: a nationwide, register-based cohort study

Back

ESC Professional Premium Access

Long-term survival in adults with congenital heart disease: a nationwide, register-based cohort study

Session: Determinants of survival and morbidity in patients with congenital heart disease

Topic: Epidemiology, Prognosis, Outcome

Speaker: Associate Professor Z. Mandalenakis (Gothenburg, SE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Associate Professor Zacharias Mandalenakis

Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

0 follower

5 more presentations in this session

Patients with congenital heart disease over the age of 60: experiences of a single tertiary centre

Speaker: Miss D. Kecskemeti (Budapest, HU)

Mortality in patients with Ebstein anomaly: a two-country, population-based cohort study including 530 patients

Speaker: Mr F. Eckerstrom (Gothenburg, SE)

The patient with Down syndrome and pulmonary arterial hypertension associated with congenital heart disease: from childhood to adulthood

Speaker: Doctor R. Luna (Barcelona, ES)

Risk predictors and outcomes of infective endocarditis among adult patients with congenital heart disease

Speaker: Doctor M. Fedchenko (Gothenburg, SE)

The risk spectrum of infective endocarditis among patients with congenital heart diseases

Speaker: Doctor E. Havers-Borgersen (Copenhagen, DK)

Access the full session

Determinants of survival and morbidity in patients with congenital heart disease

Speakers: Associate Professor Z. Mandalenakis, Miss D. Kecskemeti, Mr F. Eckerstrom, Doctor R. Luna, Doctor M. Fedchenko...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources